Newsroom
Category
June 15, 2021
Dr. Jose Cadena Zuluaga, Infectious Diseases, spoke on a Colombia radio program regarding the advantages of Johnson & Johnson’s Janssen vaccine arriving in Colombia. The advantages include that it has only one dose and does not require refrigeration as the other vaccines. Listen here.
June 15, 2021
This Texas Public Radio news brief is about the biotechnology company Novavax releasing Phase 3 clinical trial results. UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19. Read the story.
June 15, 2021
Dr. Barbara Taylor, Infectious Diseases, and the great work of the Novavax research team of UT Health San Antonio and University Health, are featured in the San Antonio Business Journal. The local site of the international clinical trial by the COVID-19 Prevention Network enrolled more than 175 participants. Read the story.
June 15, 2021
Dr. Ruth Berggren, Infectious Diseases, Center for Medical Humanities and Ethics, spoke to KSAT 12 TV audiences on the topic that the COVID-19 vaccine can be taken at the same time as other vaccines, according to the CDC. Watch the story.
June 14, 2021
Dr. Jason Bowling, Infectious Diseases, appeared in this KENS 5 story about the CDC’s plan to hold an emergency meeting to discuss COVID-19 vaccine concerns involving heart inflammation, mainly in teenage boys and young men. Watch the story.
June 14, 2021
Dr. Yogesh Gupta, Biochemistry/Structural Biology/Greehey Children’s Cancer Research Institute, spoke to News 4 San Antonio on the topic of the recent published findings in Nature Communications about the COVID-19 virus using metal ions, like magnesium and calcium in our bodies, as a disguise to hide itself from our immune systems. Watch the story.